Clinical Trial Update: The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in Russia evaluating the efficacy of a therapy for patients with acute myeloid leukemia and Down syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Down Syndrome

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: AML (Acute Myelogenous Leukemia), Down Syndrome (DS) | Phase 3 | Status: RECRUITING